Finding Predispositions to Serious Drug Reactions
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
A better understanding of why some people are predisposed to dangerous drug interactions and serious illness is the charge of the newly formed group, International Serious Adverse Event Consortium (SAE). The Chicago Tribune's Bruce Japsen interviews SAE chairman and chief executive officer, Arthur Holden about this important subject.
Overview
A better understanding of why some people are predisposed to dangerous drug interactions and serious illness is the charge of the newly formed group, International Serious Adverse Event Consortium (SAE). The Chicago Tribune's Bruce Japsen interviews SAE chairman and chief executive officer, Arthur Holden about this important subject.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?